Effect of Lactobacillus sakei OK67 in Reducing Body and Visceral Fat in Lifestyle-Modified Overweight Individuals: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Obesity is a global health problem that affects the quality of life. It is a multidimensional chronic risk factor for major medical conditions, such as cardiovascular diseases, diabetes, and cancer. This clinical trial evaluated the efficacy of OK67 (DW2010), a lactic acid bacterium, in reducing bod...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nutrients 2023-07, Vol.15 (13), p.3074
Hauptverfasser:	Oh, Seong-Jun, Cho, Young-Gyu, Kim, Dong-Hyun, Hwang, Yun-Ha
Format:	Artikel
Sprache:	eng
Schlagworte:	Abdomen Body fat Body mass Body Mass Index Body size Body weight Cardiovascular diseases Clinical trials Computed tomography Diabetes mellitus Double-Blind Method Double-blind studies Dual energy X-ray absorptiometry Global health Humans Insulin resistance Intra-Abdominal Fat - diagnostic imaging Kinases Lactic acid Lactobacillus sakei Lactobacillus sakei OK67 (DW2010) Latilactobacillus sakei Life Style Obesity overweight Overweight - drug therapy Placebos probiotics Public health Quality of Life Risk factors visceral fat
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Obesity is a global health problem that affects the quality of life. It is a multidimensional chronic risk factor for major medical conditions, such as cardiovascular diseases, diabetes, and cancer. This clinical trial evaluated the efficacy of OK67 (DW2010), a lactic acid bacterium, in reducing body and visceral fat in overweight individuals (body mass index ≥25 kg/m and
ISSN:	2072-6643 2072-6643
DOI:	10.3390/nu15133074